Rising demand for personalized medications and globalization of clinical trials are the two chief growth drivers in this segment. Besides this, impending patent expiry of blockbuster drugs and emergence of biosimilars have spurred growth prospects in the clinical trials market. However, a lack of clear understanding of biosimilars may make clinical trials a daunting task. Nonetheless, digitization in biomedical research offers lucrative prospects for growth.
Our research studies highlight trends that market players should tap into for sustainable growth. We also identify key hurdles and recommend solutions to overcome them.
Automotive Parts Market Research Reports
Aug, 2018 | 173 pages
This report on the rheumatoid arthritis drugs market analyzes the current and future scenario of the global market. Rise in geriatric population, high prevalence of rheumatoid arthritis, and increase in patient preference for biological origin drugs are major drivers of the global rheumatoid arthritis drugs market.